Psychedelic developer Bright Minds Biosciences lists NASDAQ with hopes of fighting Dravet syndrome

Effective Today – Bright Minds Biosciences’ shares are traded on the Nasdaq under the symbol “DRUG”. Bright Minds is already listed on the Canadian Stock Ex